Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
Published on: November 8, 2024
Anogenital warts in pediatric population
Miguel Costa-Silva1, Inês Fernandes2, Acácio Gonçalves Rodrigues2
1Department of Dermatology and Venereology, Centro Hospitalar São João, EPE, Faculdade de Medicina da Universidade do Porto - Porto, Portugal.
Insights
Anogenital warts in children can be challenging, especially concerning sexual abuse. Non-sexual transmission is likely in young children, while older children may indicate sexual abuse.
Area of Science:
- Pediatrics
- Dermatology
- Infectious Diseases
Background:
- Anogenital warts in children present diagnostic challenges, particularly regarding potential sexual abuse.
- Human papillomavirus (HPV) transmission routes in pediatric populations require careful consideration.
Purpose of the Study:
- To review current knowledge on pediatric anogenital warts, transmission, and sexual abuse association.
- To propose a multidisciplinary approach for evaluating children with anogenital warts.
Main Methods:
- Systematic literature review (2000-2016) in Portuguese and English.
- Databases searched: ISI Web of Knowledge and PubMed.
- Inclusion criteria: Children aged 12 years or younger.
Main Results:
- Both sexual and non-sexual HPV transmission in children are documented.
- Sexual transmission is more probable in children over 4 years old.
- Non-sexual transmission should be considered in children under 4, absent other indicators of abuse.
Conclusions:
- The likelihood of sexual abuse association with HPV infection increases with age.
- HPV genotyping's role in sexual abuse evaluation is debated.
- A multidisciplinary approach enhances the identification of sexual abuse in children with anogenital warts.
Abstract:
The approach to children with anogenital warts in the context of sexual abuse is a challenge in clinical practice. This study aims to review the current knowledge of anogenital warts in children, the forms of transmission, and the association with sexual abuse and to propose a cross-sectional approach involving all medical specialties. A systematic review of the literature was conducted in Portuguese and English from January 2000 to June 2016 using the ISI Web of Knowledge and PubMed databases. Children aged 12 years or younger were included. The ethical and legal aspects were consulted in the Declaration and Convention on the Rights of Children and in the World Health Organization. Non-sexual and sexual transmission events of human papillomavirus in children have been well documented. The possibility of sexual transmission appears to be greater in children older than 4 years. In the case of anogenital warts in children younger than 4 years of age, the possibility of non-sexual transmission should be strongly considered in the absence of another sexually transmitted infection, clinical indicators, or history of sexual abuse. The importance of human papillomavirus genotyping in the evaluation of sexual abuse is controversial. A detailed medical history and physical examination of both the child and caregivers are critical during the course of the investigation. The likelihood of an association between human papillomavirus infection and sexual abuse increases directly with age. A multidisciplinary clinical approach improves the ability to identify sexual abuse in children with anogenital warts.
Related Concept Videos
Sexually Transmitted Infections
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Sex-linked Disorders
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

